Figma, Inc.
FIG NYSE Services-Prepackaged Software Financials FY2023βFY2025
What Figma, Inc. does
No business description yet.
- Legal name
- Figma, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 18, 2026
- Accession Β· CIK
- 0001628280-26-009228
0001579878
Revenue and margins
Figma, Inc. had $1.1B of revenue in fiscal 2025, up 41.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $246M in fiscal 2025, 23.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Figma, Inc. returned $0.0M to shareholders in fiscal 2025, 0% of free cash flow. The diluted share count rose 72.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably Figma, Inc. can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $1.3B | $1.5B | $1.7B |
| Current ratio | β | 3.7x | 2.6x |
| Quick ratio | β | 3.7x | 2.6x |
| Total assets | β | $1.8B | $2.3B |
| Total liabilities | β | $469M | $838M |
| Shareholders' equity | $1.0B | $1.3B | $1.5B |
| Net debt (β = net cash) | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 5 | 3 / 8 |
| Accruals ratio | β | β37.4% | β72.5% |
| Altman Z'' | β | 3.68 | β0.37 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $505M | $749M | $1.1B |
| Gross profit | $460M | $661M | $870M |
| Research and development | $165M | $751M | $1.0B |
| Operating income | β$73.5M | β$877M | β$1.3B |
| Pretax income | $946M | β$793M | β$1.2B |
| Income tax | $208M | β$61.0M | $24.8M |
| Net income | $738M | β$732M | β$1.3B |
| Net income to common | $286M | β$732M | β$1.3B |
| Diluted EPS | $1.62 | β$3.74 | β$3.71 |
| Diluted shares | 0.19B | 0.20B | 0.34B |
| Cash flow | |||
| Cash from operations | $1.0B | β$61.7M | $251M |
| Capital expenditure | $3.7M | $2.0M | $4.4M |
| Free cash flow | $1.0B | β$63.7M | $246M |
| Depreciation and amortization | $8.5M | $7.7M | $15.6M |
| Stock-based compensation | $2.7M | $948M | $1.4B |
| Acquisitions | $0.0M | $0.0M | $58.3M |
| Share buybacks | $0.0M | $0.9M | $0.0M |
| Dividends and buybacks | $0.0M | $0.9M | $0.0M |
| Balance sheet | |||
| Cash and short-term investments | $1.3B | $1.5B | $1.7B |
| Current assets | β | $1.6B | $2.0B |
| Current liabilities | β | $447M | $776M |
| Property and equipment, net | β | $15.0M | $20.0M |
| Goodwill | $11.4M | $11.4M | $101M |
| Intangible assets | β | $2.5M | $19.1M |
| Total assets | β | $1.8B | $2.3B |
| Total liabilities | β | $469M | $838M |
| Preferred stock | β | $329M | β |
| Shareholders' equity | $1.0B | $1.3B | $1.5B |
| Margins | |||
| Gross margin | 91.2% | 88.3% | 82.4% |
| Operating margin | β14.5% | β117.1% | β122.2% |
| EBITDA margin | β12.9% | β116.1% | β120.7% |
| Net margin | 146.1% | β97.7% | β118.4% |
| FCF margin | 206.7% | β8.5% | 23.3% |
| Returns | |||
| Return on capital employed | β | β65.2% | β82.1% |
| Return on equity | 70.7% | β61.9% | β88.2% |
| Return on assets | β | β40.8% | β60.4% |
| Return on tangible equity | 27.7% | β55.9% | β90.0% |
| Growth | |||
| Revenue growth | β | 48.4% | 41.0% |
| Net income growth | β | β199.2% | β |
| EPS growth | β | β330.9% | β |
| FCF growth | β | β106.1% | β |
| Share count change | β | 4.5% | 72.3% |
| Financial health | |||
| Current ratio | β | 3.7x | 2.6x |
| Quick ratio | β | 3.7x | 2.6x |
| Capital allocation | |||
| Capex / revenue | 0.7% | 0.3% | 0.4% |
| Stock comp / revenue | 0.5% | 126.5% | 129.2% |
| Payouts / FCF | 0.0% | β | 0.0% |
| Quality scores | |||
| Piotroski F-score | β | β | 3.0 |
| Altman Z'' | β | 3.7 | β0.4 |
| Accruals ratio | β | β37.4% | β72.5% |
Source: SEC EDGAR XBRL filings (CIK 0001579878). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.